Pharmacotherapy for mild hypertension

BACKGROUND: People with no previous cardiovascular events or cardiovascular disease represent a primary prevention population. The benefits and harms of treating mild hypertension in primary prevention patients are not known at present. This review examines the existing randomized controlled trial (...

Descripción completa

Detalles Bibliográficos
Autores principales: Diao, Diana, Wright, James M., Cundiff, David K., Gueyffier, Francois
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Paulista de Medicina - APM 2013
Materias:
Cochrane Highlights
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522316/
https://www.ncbi.nlm.nih.gov/pubmed/23338742
http://dx.doi.org/10.1590/S1516-31802012000600012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522316/
https://www.ncbi.nlm.nih.gov/pubmed/23338742
http://dx.doi.org/10.1590/S1516-31802012000600012

Ejemplares similares